Answer and explanation
Correct answer: B. Ciclosporin
Three drug groups cause gingival enlargement: the anticonvulsant phenytoin, the immunosuppressant ciclosporin and the calcium channel blockers, especially nifedipine. Ciclosporin is a mainstay of anti-rejection therapy after organ transplantation and produces enlargement in a substantial proportion of patients, typically beginning in the interdental papillae within the first months of treatment, firm and lobulated or more vascular and bleeding than phenytoin enlargement, and most marked on the anterior labial gingiva. Severity correlates with plaque control and, to a degree, with dose, and the problem is compounded when a transplant patient also takes nifedipine or amlodipine for drug-induced hypertension. Management is meticulous plaque control and scaling, a request to the physician to consider tacrolimus or another alternative, and gingivectomy or flap surgery for persistent enlargement, which tends to recur while the drug continues. Option A, prednisolone, suppresses inflammation and does not enlarge the gingiva. Options C and D, a statin and a proton pump inhibitor, have no recognised association with gingival overgrowth. Exam tip: phenytoin, ciclosporin and nifedipine are the trio; a transplant history points to ciclosporin, epilepsy to phenytoin and hypertension or angina to a calcium channel blocker.
Reference: Newman MG, Takei HH, Klokkevold PR, Carranza FA. Newman and Carranza's Clinical Periodontology, 13th ed. Elsevier; chapter on gingival enlargement (page to be verified by reviewer).
Written by Dr. Placeholder, BDS (NMC No. —). Reviewer signature, NMC number and review date pending.

